Clinical trial Recruiting at 1 site Interventional Ages 15 and up Women only

Reducing psychological barriers to PrEP use during pregnancy and postpartum in Cape Town

Official title: Reducing Psychological Barriers to PrEP Persistence Among Pregnant and Postpartum Women in Cape Town, South Africa

Run by Boston University Charles River Campus · NCT05624931 · Data updated 2026-11-12

This project will test a brief cognitive-behavioral program to see if treating depression and posttraumatic stress helps pregnant and postpartum women in Cape Town stay on PrEP.

More Depression trials

Quick facts

Study typeInterventional
Ages15 Years and up
SexWomen only
Enrollment118 (estimated)
SponsorBoston University Charles River Campus
Academic / other
Locations2 sites (Boston, Massachusetts and 1 other locations)
StatusRecruiting
StartedApril 17, 2025
Main results expectedFebruary 28, 2027
Study endsJuly 30, 2027
Registry record updatedJuly 17, 2026
Trial IDNCT05624931 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are HIV-negative pregnant or postpartum women (aged 15+) receiving antenatal care at the Gugulethu MOU who recently started PrEP or have documented or self-reported PrEP adherence challenges and moderate-to-severe PTSD or depression.

Probably not a fit

Women without clinically significant PTSD or depression, those who are HIV-positive, or individuals with active psychosis or untreated bipolar disorder are unlikely to benefit from this intervention as tested.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional project develops and tests the feasibility and acceptability of a brief cognitive-behavioral therapy (CBT)-based intervention delivered alongside enhanced usual care to address depression and posttraumatic stress among pregnant and postpartum women. Participants are HIV-negative pregnant women (age 15+) who recently started PrEP or have documented adherence challenges and screen positive for moderate-to-severe PTSD and/or depression. The intervention is delivered at the Gugulethu Midwife Obstetric Unit in collaboration with Boston University and the University of Cape Town, with outcomes focused on PrEP adherence and persistence during pregnancy and the postpartum transition. The study compares the CBT intervention to enhanced treatment-as-usual and examines mechanisms linking mental health symptoms to PrEP adherence.

Why it matters

Potential benefit: If successful, the intervention could improve PrEP persistence during pregnancy and breastfeeding and reduce maternal HIV infections by addressing mental health barriers.

How similar studies have gone: CBT and other mental-health interventions have improved medication adherence in other settings, but applying a brief CBT approach specifically to PrEP persistence during pregnancy and postpartum in South Africa is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* For participants across all three aims are:

  * Female sex
  * Aged 15+
  * Pregnant and presenting antenatal care at the Gugulethu MOU
  * HIV-negative
  * Recent PrEP initiation (\<1 month ago) or PrEP adherence challenges, either documented (\>2 weeks late to pick up PrEP refill) or self-reported
  * Moderate to severe symptoms of posttraumatic stress and/or depression (defined as a score of ≥31 on PTSD Checklist for DSM-5 (PCL-5) and/or a score of ≥13 on the Edinburgh Postnatal Depression Scale (EPDS). Cutoff scores may be adjusted by 3-5 points to facilitate recruitment.

Exclusion Criteria:

* There are no exclusion criteria with respect to parity or gravidity.

  * Participants who are unable to provide informed consent or assent in English or Xhosa
  * Have a significant psychiatric illness (e.g., active psychotic disorder or untreated bipolar disorder) that could interfere with participation will be excluded. Positive symptoms of active psychosis or mania will be assessed by the research assistants. They will be trained to identify delusions, hallucinations, disorganized or pressured speech, flight of ideas, and grandiosity as they speak to potential participants.
  * Potential participants will also be asked if they have any health conditions that make it difficult for them to travel to the clinic.

Where it's running

  • Gugulethu Midwife Obstetric Unit (MOU)
    Cape Town, Western Cape, South Africa
    Recruiting
  • Boston University
    Boston, Massachusetts, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Amelia Stanton, PhD — Boston University
  • Study coordinator: Amelia M Stanton, PhD
  • Email: stantona@bu.edu
  • Phone: 617-353-2580

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.